Company Filing History:
2 out of 92 
1 out of 230 
1 out of 356 
Years Active: 2013-2022
Title: Mark James Schulz: Innovator in Pharmaceutical Compounds
Introduction
Mark James Schulz is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work primarily focuses on developing novel compounds that have potential therapeutic applications.
Latest Patents
Among his latest patents, Schulz has developed modulators of the stimulator of interferon genes (STING). These compounds are characterized by a specific formula that includes various defined components. Another significant invention is the Enhancer of Zeste Homolog 2 inhibitors, which relates to novel compounds that inhibit EZH2 and includes pharmaceutical compositions containing these compounds.
Career Highlights
Throughout his career, Schulz has worked with prominent companies, including GlaxoSmithKline Intellectual Property Limited and GlaxoSmithKline Intellectual Property Development Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Schulz has collaborated with notable colleagues, including Juan I Luengo and Stuart Paul Romeril. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Mark James Schulz is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact medical treatments significantly. His contributions to the field are marked by his innovative patents and collaborations with industry professionals.